Data / New clinical trials / Diabetes Mellitus, Type 2
Diabetes Mellitus, Type 2 trials: 1,265 new since Nov 2024
The full list. New Diabetes Mellitus, Type 2 clinical trials: 1,265 rows for $63.25, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 55 rows a month. The new rows come each week by email, $19 a month.
Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.
For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/condition/diabetes-mellitus-type-2, and every list with its row count and price is at https://specstream.ai/data/lists.json.
Updated November 9, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).
1,265 clinical studies in Diabetes Mellitus, Type 2 were first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026; 304 have an industry sponsor and 745 are recruiting or about to. The newest, NCT07926152, was posted on November 9, 2026: Exercise and Protein to Reduce Muscle Loss During GLP-1-Based Treatment in Type 2 Diabetes (German Diabetes Center).
The request: Every new Diabetes Mellitus, Type 2 clinical trial on ClinicalTrials.gov, with the sponsor, phase, sites and the listed contact. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.
- 1,265New trials
- 304Industry sponsored
- 745Recruiting or not yet
- November 9, 2026Latest posted
Newest trials
The newest 100 of 1,265, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.
| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
|---|---|---|---|---|---|---|---|---|---|
| November 9, 2026 | NCT07926152 | Exercise and Protein to Reduce Muscle Loss During GLP-1-Based Treatment in Type 2 Diabetes | German Diabetes Center | Not applicable | Not yet recruiting | Type 2 Diabetes (T2DM), Obesity & Overweight, Sarcopenia | 94 | Germany | clinicaltrials.gov |
| November 9, 2026 | NCT07926074 | AI Chatbot Mobile App for Self-Management in Type 2 Diabetes | Alexandria University | Not applicable | Not yet recruiting | Type 2 Diabetes Mellitus | 120 | Egypt | clinicaltrials.gov |
| November 9, 2026 | NCT07925801 | Relacorilant in Patients With Poorly Controlled Type 2 Diabetes and Autonomous Cortisol Secretion | The University of Texas Health Science Center at San Antonio | Phase 1/2 | Not yet recruiting | Type 2 Diabetes, Hypercortisolism | 34 | United States | clinicaltrials.gov |
| November 9, 2026 | NCT07924618 | Ocular Changes in Patients Using Tirzepatide or Semaglutide | Istanbul University | Observational | Recruiting | Type 2 Diabetes Mellitus, Obesity | 40 | Turkey (Türkiye) | clinicaltrials.gov |
| November 9, 2026 | NCT07924436 | Whole-Body Vibration Training in Women With Obesity With and Without Type 2 Diabetes | Pamukkale University | Not applicable | Recruiting | Obesity, Diabetes Mellitus, Type 2 | 30 | Turkey (Türkiye) | clinicaltrials.gov |
| November 6, 2026 | NCT07923357 | A Phase 2 Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SAL0150 Tablets in Subjects With Type 2 Diabetes Mellitus | Shenzhen Salubris Pharmaceuticals Co., Ltd. | Phase 2 | Not yet recruiting | Type 2 Diabetes Mellitus (T2DM), Type 2 Diabetes, T2DM | 364 | China | clinicaltrials.gov |
| November 6, 2026 | NCT07922694 | Obesity-Related Indices and Albuminuria in Type 2 Diabetes | Assiut University | Observational | Not yet recruiting | Obesity and Diabetes Mellitus, Type 2, Albuminuria | 349 | clinicaltrials.gov | |
| November 6, 2026 | NCT07922330 | A Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These... | AstraZeneca | Phase 3 | Not yet recruiting | Obesity, Overweight, Type 2 Diabetes Mellitus | 330 | China, India | clinicaltrials.gov |
| November 6, 2026 | NCT07922148 | Osilodrostat for Glycemic Control in Mild Autonomous Cortisol Secretion (MACS) With Difficult-To-Control Type 2 Diabetes - A Randomized... | Beckey Trinh | Phase 2 | Not yet recruiting | Mild Autonomous Cortisol Secretion (MACS), Diabetes Mellitus (Type 2) | 44 | Switzerland | clinicaltrials.gov |
| November 6, 2026 | NCT07921901 | Comparison of Functional Inspiratory Muscle Training and Combined Exercise Training in Individuals With Type 2 Diabetes | İrem Çaylak Yetüt | Not applicable | Not yet recruiting | Type 2 Diabetes Mellitus | 39 | Turkey (Türkiye) | clinicaltrials.gov |
| November 6, 2026 | NCT07920939 | Efficacy and Safety of Once-Weekly SHR-3167 Compared With Once-Daily Insulin Glargine in Adults With Insulin-Naive Type 2 Diabetes | Jiangsu HengRui Medicine Co., Ltd. | Phase 3 | Not yet recruiting | Type 2 Diabetes | 450 | China | clinicaltrials.gov |
| November 5, 2026 | NCT07920653 | Pilates vs. Core Stabilization for Balance and Mobility in Elderly Type 2 Diabetics | Beni-Suef University | Not applicable | Not yet recruiting | Mellitus Balance Deficits Postural Balance Mobility Limitation, Type 2 Diabetes Mellitus | 40 | clinicaltrials.gov | |
| November 5, 2026 | NCT07920640 | Fuling Yunhua Granules and Dihuang Baoyuan Granules in Adults With Type 2 Diabetes and Poor Glycemic Control Despite Lifestyle Intervention | Beijing Supreme Life Pharmaceutical Technology Co., Ltd. | Phase 2 | Not yet recruiting | Diabetes Mellitus, Type 2 | 150 | China | clinicaltrials.gov |
| November 5, 2026 | NCT07920510 | Effects of Treadmill Walking Speeds With Cognitive Training on HRV, Gait, and Motor-Cognitive in Elderly With Type 2 DM | University of Phayao | Not applicable | Active not recruiting | Diabetes Mellitus, Type 2 | 60 | Thailand | clinicaltrials.gov |
| November 5, 2026 | NCT07920341 | Inter-Arm Differences in Continuous Glucose Monitor Readings in Adults With Diabetes | University of the Pacific | Not applicable | Not yet recruiting | Continuous Glucose Monitoring, Type 1 Diabetes, Type 2 Diabetes | 60 | United States | clinicaltrials.gov |
| November 5, 2026 | NCT07920042 | A Nurse-Led Personalized Self-Management Counseling Intervention to Improve Medication Adherence and Glycemic Control in Adults With Type 2... | University of Basrah | Not applicable | Not yet recruiting | Medication Adherence, Glycemic Control for Diabetes Mellitus | 128 | Iraq | clinicaltrials.gov |
| November 5, 2026 | NCT07919795 | Beta-2-Trace Protein in Diabetic Nephropathy | Assiut University | Observational | Not yet recruiting | Diabetic Nephropathy Type 2, Type 2 Diabetes Mellitus | 80 | clinicaltrials.gov | |
| November 5, 2026 | NCT07919236 | Continuous Glucose Monitoring Systems in People With Type 2 Diabetes Not Treated With Insulin | Medical University of Bialystok | Not applicable | Recruiting | Type 2 Diabetes | 50 | Poland | clinicaltrials.gov |
| November 5, 2026 | NCT07918508 | Community Health Worker Nutrition Self-Management Support for Cardio-Kidney-Metabolic Health | Florida International University | Not applicable | Not yet recruiting | Hypertension (HTN), CKD - Chronic Kidney Disease, Cardio-Renal Syndrome, Food Insecurity, Type 2 Diabetes | 200 | United States | clinicaltrials.gov |
| November 5, 2026 | NCT07918170 | LEANDIP: Lean Diabetes in Asian Indians | Diabetes Foundation, India | Observational | Not yet recruiting | Lean Diabetes Mellitus, Type 2 Diabetes, β-cell Dysfunction, Metabolic Abnormalities, Diabetes in Asian Indian | 151 | clinicaltrials.gov | |
| November 5, 2026 | NCT07917936 | IL-4 and IL-17 Responses to Periodontal Therapy in Patients With Type 2 Diabetes | Dicle University | Observational | Completed | Periodontitis, Type 2 Diabetes Mellitus | 45 | Turkey (Türkiye) | clinicaltrials.gov |
| November 4, 2026 | NCT07916753 | Use and Acceptability of an AI-Assisted Health Application for Individuals Living With a Chronic Condition | Fondation Net-Care.ch | Not applicable | Not yet recruiting | Hypertension, Diabetes Mellitus, Type 2, Obesity | 1,600 | Switzerland | clinicaltrials.gov |
| November 4, 2026 | NCT07916584 | A Nurse-Led Digital Coaching Program to Improve Blood Sugar Control in Adults With Type 2 Diabetes | Alexandria University | Not applicable | Not yet recruiting | Type 2 Diabetes Mellitus | 160 | Bahrain | clinicaltrials.gov |
| November 4, 2026 | NCT07916428 | AI-Based Model for Predicting Type 2 Diabetes Risk Using Lifestyle Factors Among Senior Nursing Students | Alexandria University | Observational | Not yet recruiting | Type 2 Diabetes Mellitus | 200 | Egypt | clinicaltrials.gov |
| November 4, 2026 | NCT07915609 | A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2... | Pfizer | Phase 3 | Recruiting | Obesity, Overweight and/or Obesity, Knee Osteoarthritis, Diabetes Melliuts, Type 2 | 756 | United States | clinicaltrials.gov |
| November 4, 2026 | NCT07915596 | Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Observational | Completed | Type 2 Diabetes Mellitus, Nonalcoholic Fatty Liver Disease | 792 | Bangladesh | clinicaltrials.gov |
| November 3, 2026 | NCT07913698 | Clinical Research Trial to Study Insulin Sensitivity Using Automated Glucose Clamp Technology | Profil Institut für Stoffwechselforschung GmbH | Observational | Not yet recruiting | Obesity Type 2 Diabetes Mellitus, Obese Adults, Type 2 Diabetes Mellitus | 50 | United States | clinicaltrials.gov |
| November 3, 2026 | NCT07913061 | A Study Comparing SHR-3167 With Insulin Degludec in Adults With Type 2 Diabetes Currently Treated With Basal Insulin | Jiangsu HengRui Medicine Co., Ltd. | Phase 3 | Not yet recruiting | Diabetes Mellitus, Type 2 | 680 | China | clinicaltrials.gov |
| November 2, 2026 | NCT07911007 | Differentiating Heart Disease Between Adult-onset Autoimmune and Type 2 Diabetes | University of Roma La Sapienza | Not applicable | Recruiting | Diabete Mellitus, Autoimmune Diabetes, Latent Autoimmune Diabetes in Adult (LADA), Type 2 Diabetes, Heart Disease... | 200 | Italy | clinicaltrials.gov |
| November 2, 2026 | NCT07910968 | SWitching to Appropriate Prescription in Cardiovascular-Kidney-Metabolic Syndrome | Kaiser Permanente | Not applicable | Not yet recruiting | Cardiovascular-kidney-metabolic Syndrome, Diabete Type 2, Chronic Kidney Disease, Heart Failure | 1,200 | United States | clinicaltrials.gov |
| October 30, 2026 | NCT07907965 | A Study on the Safety and Clinical Efficacy of Guominkang in the Treatment of Diabetic Kidney Disease | Beijing University of Chinese Medicine | Phase 2 | Active not recruiting | Diabetic Kidney Disease (DKD), Type 2 Diabetes, Albuminuria | 15 | China | clinicaltrials.gov |
| October 30, 2026 | NCT07907536 | Acupuncture Plus Mecobalamin for Diabetic Cardiac Autonomic Neuropathy | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Not applicable | Recruiting | Diabetic Cardiovascular Autonomic Neuropathy, Type 2 Diabetes Mellitus, Diabetic Neuropathies | 60 | China | clinicaltrials.gov |
| October 30, 2026 | NCT07906470 | Physiologic Insulin Resensitization (PIR) Treatment in Patients With a Diagnosis of Type 2 Diabetes Mellitus (T2DM) | University of Alabama at Birmingham | Not applicable | Not yet recruiting | Type 2 Diabetes Mellitus | 60 | United States | clinicaltrials.gov |
| October 29, 2026 | NCT07905209 | Evaluation of MTHFR and DNMT3B Gene Polymorphisms Along With Periodontal Clinical Parameters in Healthy Individuals and Individuals With... | Akdeniz University | Observational | Active not recruiting | Periodontitis, Type 2 Diabetes Mellitus (DM) | 200 | Turkey (Türkiye) | clinicaltrials.gov |
| October 28, 2026 | NCT07901673 | Information-Based Interventions for Influenza Vaccination Among Older Adults With Diabetes in Yangzhou, China | Southeast University, China | Not applicable | Completed | Diabetes Mellitus, Type 2, Influenza | 759 | China | clinicaltrials.gov |
| October 28, 2026 | NCT07901595 | Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PAL-119 in Healthy Volunteers and Adult Participants With Type 1 or Type 2... | Paulex Bio Inc. | Phase 1/2 | Not yet recruiting | Healthy Volunteers and Diabetes Participants | 147 | clinicaltrials.gov | |
| October 28, 2026 | NCT07900633 | A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk | Eli Lilly and Company | Phase 3 | Not yet recruiting | Obesity, Overweight, Cardiovascular Diseases, Diabetes Mellitus, Type 2 | 3,000 | Argentina, Australia, Brazil, Canada, China, Czechia, France, Germany, Hungary... | clinicaltrials.gov |
| October 26, 2026 | NCT07896109 | A Research Study to Check the Safety of NNC9836-0001 When Given to Healthy Participants and Participants With Type 2 Diabetes | Novo Nordisk A/S | Phase 1 | Not yet recruiting | Diabetes Mellitus, Type 2 | 121 | Germany | clinicaltrials.gov |
| October 23, 2026 | NCT07891234 | Effect of SGLT2 Inhibitor on Metabolic-Dysfunction-Associated Fatty Liver Disease in Patients With Insulin Resistance | Sherihan AboElyazed Mohamed Khalil | Phase 4 | Not yet recruiting | MAFLD in Prediabetes and Diabetes | 66 | Egypt | clinicaltrials.gov |
| October 22, 2026 | NCT07890818 | Transitioning Recently Admitted Patients With Non-Insulin and Insulin-treated Type 2 Diabetes to Innovative Glucose Monitoring | University of Cincinnati | Not applicable | Not yet recruiting | Type 2 Diabetes | 218 | United States | clinicaltrials.gov |
| October 22, 2026 | NCT07890740 | Continuous Glucose Monitoring and Dietary Self-Management in Adults in Namwon | Ji-Yeob Choi | Not applicable | Not yet recruiting | Prediabetes, Dietary Self-Management, Diabetes Mellitus, Type 2 | 860 | South Korea | clinicaltrials.gov |
| October 22, 2026 | NCT07889648 | A Clinical Study to Evaluate the Effects of Enicepatide Versus Tirzepatide in Participants With Type 2 Diabetes and Inadequate Blood Sugar... | Hoffmann-La Roche | Phase 3 | Not yet recruiting | Type 2 Diabetes Mellitus | 948 | clinicaltrials.gov | |
| October 22, 2026 | NCT07889453 | Metabolic Effects of Switching From Injectable Semaglutide to Tirzepatide | LMC Diabetes & Endocrinology Ltd. | Observational | Active not recruiting | Obesity, Type 2 Diabetes (T2D) | 650 | Canada | clinicaltrials.gov |
| October 22, 2026 | NCT07889388 | RIGHTEST iFree 2 CGM in Pregnant Women With Diabetes Study | Bionime Corporation | Not applicable | Recruiting | Diabetes Mellitus, Type 1 Diabetes, Diabetes Mellitus, Type 2, Diabetes, Gestational | 104 | Germany | clinicaltrials.gov |
| October 22, 2026 | NCT07888972 | Digital Health Literacy and Diabetes Management in Type 2 Diabetes | Abant Izzet Baysal University | Observational | Not yet recruiting | Type 2 Diabetes | 348 | Turkey (Türkiye) | clinicaltrials.gov |
| October 22, 2026 | NCT07888855 | Impact of AI-Based Breath Ammonia Kidney Function Results on Clinical Pharmacist Medication Recommendations | Shanghai Pudong Hospital | Observational | Not yet recruiting | Diabetes Mellitus, Type 2, Diabetic Nephropathies | 380 | China | clinicaltrials.gov |
| October 22, 2026 | NCT07888426 | Tolerability and Safety of Nano-Tocotrienols | University of Malaya | Phase 2 | Not yet recruiting | Type 2 Diabetes Mellitus (DM) | 360 | Malaysia | clinicaltrials.gov |
| October 22, 2026 | NCT07888257 | LIfestyle MEtabotype Study B (LIME-B) | German Institute of Human Nutrition | Not applicable | Recruiting | Nutritional and Metabolic Diseases, Prediabetes, Type 2 Diabetes | 300 | Germany | clinicaltrials.gov |
| October 21, 2026 | NCT07887477 | Different Diets in Different Diabetes - 4DI PLAN'EAT Pilot Study | University of Bologna | Not applicable | Active not recruiting | Type 2 Diabetes | 101 | Italy | clinicaltrials.gov |
| October 21, 2026 | NCT07887334 | Hypoglycemia Risk Assessment in Elderly and Senile Female Patients With Type 2 Diabetes Mellitus | Samara State Medical University | Observational | Completed | Type 2 Diabetes Mellitus, Hypoglycemia, Frailty, Sarcopenia | 200 | Russia | clinicaltrials.gov |
| October 21, 2026 | NCT07885904 | Preventive Effectiveness of Primary Care Physician-led CGM-supported Comprehensive Intervention on Cardio-metabolic-immune Diseases in... | Xiangya Hospital of Central South University | Not applicable | Not yet recruiting | Type 2 Diabetes Mellitus | 15,400 | China | clinicaltrials.gov |
| October 21, 2026 | NCT07884903 | Chinese Overweight/Obesity Cohort: Metabolic & Comorbidity Risks | Shanxi Bethune Hospital | Observational | Not yet recruiting | Obesity & Overweight, Diabetes Mellitus, Type 2, Hypertension, Non-alcoholic Fatty Liver Disease (MASLD)... | 25,974 | China | clinicaltrials.gov |
| October 20, 2026 | NCT07883343 | Effects of Adding a Registered Dietitian to Rural Community Healthy Behavior Support Services for Management of Type 2 Diabetes | Indiana University | Not applicable | Completed | Type 2 Diabetes | 14 | United States | clinicaltrials.gov |
| October 20, 2026 | NCT07881887 | A Study of LY4167586 in Participants With Obesity or Overweight With or Without Type 2 Diabetes | Eli Lilly and Company | Phase 1 | Not yet recruiting | Obesity, Overweight, Diabetes Mellitus, Type 2 | 617 | Singapore, United States | clinicaltrials.gov |
| October 19, 2026 | NCT07881458 | A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes | Eli Lilly and Company | Phase 3 | Recruiting | Obesity, Overweight, Diabetes Mellitus, Type 2 | 1,000 | Brazil, China, Germany, Japan, Puerto Rico, Romania, South Korea, Spain... | clinicaltrials.gov |
| October 16, 2026 | NCT07878325 | Effects of a Specialized Diabetes and Heart Clinic and Detection of Unrecognized Heart Failure in People With Type 2 Diabetes and... | Odense University Hospital | Not applicable | Recruiting | Cardiovascular Disease, Cardiometabolic Diseases, Diabetes Type 2, Diabetes and Heart Failure, Heart Failure With... | 375 | Denmark | clinicaltrials.gov |
| October 16, 2026 | NCT07877948 | Comparative Study of Combination Treatment of Bionerv E+ Versus Vitamin B Complex in Treatment of Diabetic Polyneuropathy in Type 2... | BREGO Life Sciences | Not applicable | Recruiting | Diabetic Foot Ulcer (DFU), Diabetic Symmetrical Polyneuropathy | 100 | Malaysia | clinicaltrials.gov |
| October 15, 2026 | NCT07877038 | Pharmacokinetics, Safety, and Tolerability of DA-302168S Tablets in Participants With Hepatic Impairment and Normal Hepatic Function | Chendu DIAO Pharmaceutical Group CO., LTD. | Phase 1 | Not yet recruiting | Obesity, Overweight, T2DM (Type 2 Diabetes Mellitus) | 32 | clinicaltrials.gov | |
| October 15, 2026 | NCT07876401 | Effects of Progressive Muscle Relaxation on Anxiety, Depression, and Quality of Life in Adults With Type 2 Diabetes | Gul Dural | Not applicable | Completed | Type 2 Diabetes Mellitus | 80 | Turkey (Türkiye) | clinicaltrials.gov |
| October 15, 2026 | NCT07876258 | A Study in Type 2 Diabetes Patients Who Are Taking Moderate Dose Insulin, Looking at the Effects of the Medication Luseogliflozin on Risk... | Aimi Fadilah Mohamad | Phase 3 | Completed | Diabetes Mellitus Type 2 | 40 | Malaysia | clinicaltrials.gov |
| October 15, 2026 | NCT07875010 | Wearable NH₃ Sensor for Remote Non-invasive Monitoring and Diagnosis of Diabetic Kidney Disease | Shanghai Pudong Hospital | Observational | Active not recruiting | Diabetic Nephropathies MeSH:D003928, Diabetes Mellitus, Type 2, Kidney Diseases | 380 | China | clinicaltrials.gov |
| October 13, 2026 | NCT07872436 | A Study of VCT220 Tablets in Adults With Type 2 Diabetes and Inadequate Blood Glucose Control | Vincentage Pharma Co., Ltd | Phase 2 | Not yet recruiting | Type 2 Diabetes Mellitus (DM) | 120 | China | clinicaltrials.gov |
| October 13, 2026 | NCT07872358 | Bioequivalence Study to Compare Empagliflozin/Linagliptin/Metformin HCl25 mg/5 mg/1000 mg Extended Release Tablet Versus Trijardy® XR 25... | Humanis Saglık Anonim Sirketi | Phase 1 | Completed | Type 2 Diabetes Mellitus (T2DM), Cardiovascular Diseases | 36 | India | clinicaltrials.gov |
| October 13, 2026 | NCT07871370 | Silymarin Effects on Fatty Liver in Type 2 Diabetics | University of Mosul | Not applicable | Completed | Type 2 Diabetes, Fatty Liver | 120 | Iraq | clinicaltrials.gov |
| October 13, 2026 | NCT07870122 | Sleep Quality, Adiposity and Diet Quality | Izmir Democracy University | Observational | Not yet recruiting | Type 2 Diabetes Mellitus, Health Adult Subjects | 209 | Turkey (Türkiye) | clinicaltrials.gov |
| October 9, 2026 | NCT07868666 | Clinical Decision Support for SGLT2i After AKI in Type 2 Diabetes | University of Minnesota | Not applicable | Recruiting | Type 2 Diabetes Mellitus, Acute Kidney Injury, Chronic Kidney Diseases | 250 | United States | clinicaltrials.gov |
| October 9, 2026 | NCT07868601 | LIfestyle MEtabotype Study A | German Institute of Human Nutrition | Observational | Recruiting | Nutritional and Metabolic Diseases, Prediabetes, Type 2 Diabetes | 300 | Germany | clinicaltrials.gov |
| October 9, 2026 | NCT07868354 | A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New... | Novo Nordisk A/S | Phase 1 | Recruiting | Overweight, Obesity, Type 2 Diabetes | 60 | United States | clinicaltrials.gov |
| October 9, 2026 | NCT07868250 | KPSC MNT Pilot RCT | Kaiser Permanente | Not applicable | Recruiting | Type 2 Diabetes | 600 | United States | clinicaltrials.gov |
| October 8, 2026 | NCT07866235 | Comparing The Effect Of Empagliflozin With Dapagliflozin In Reducing Proteinuria In Diabetic Patients With Chronic Kidney Disease With eGFR... | Lahore General Hospital | Not applicable | Completed | Diabetic Nephropathies, Diabetes Mellitus, Type 2, Renal Insufficiency, Chronic | 116 | Pakistan | clinicaltrials.gov |
| October 8, 2026 | NCT07866066 | Maridebart Cafraglutide Versus Semaglutide in Participants With Type 2 Diabetes | Amgen | Phase 3 | Recruiting | Diabetes Mellitus, Type 2 | 1,300 | Canada, United States | clinicaltrials.gov |
| October 8, 2026 | NCT07864805 | Electromagnetic Therapy, Peripheral Vascular Diseases, Diabetes | Ashraf Abdelaal | Not applicable | Completed | Peripheral Arterial Disease (PAD), Diabete Type 2, Gait Abnormality, Quality of Life | 60 | Saudi Arabia | clinicaltrials.gov |
| October 7, 2026 | NCT07864168 | Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 Diabetes | Medtronic MiniMed, Inc. | Not applicable | Recruiting | Type 1 Diabetes, Type 2 Diabetes | 1,500 | United States | clinicaltrials.gov |
| October 7, 2026 | NCT07862452 | Tracking Income Dynamics and Everyday Health Study | University of Pennsylvania | Not applicable | Not yet recruiting | HIV, Hypertension, Hypercholerolemia, Type 2 Diabetes | 400 | United States | clinicaltrials.gov |
| October 6, 2026 | NCT07861308 | Diabetes Distress, Medication Adherence Barriers, Self-Management, and Glycemic Control in Adults With Type 2 Diabetes | Bilecik Seyh Edebali Universitesi | Observational | Not yet recruiting | Type 2 Diabetes Mellitus | 137 | clinicaltrials.gov | |
| October 2, 2026 | NCT07855133 | A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New... | Novo Nordisk A/S | Phase 1 | Recruiting | Overweight, Obesity, Type 2 Diabetes | 60 | United States | clinicaltrials.gov |
| October 2, 2026 | NCT07854990 | Clinical Predictors and Therapeutic Gaps in CKM Syndrome Among Adults With Type 2 Diabetes | Assiut University | Observational | Not yet recruiting | Type 2 Diabetes Mellitus, Cardiovascular-Kidney-Metabolic Syndrome, Diabetic Kidney Disease | 231 | Egypt | clinicaltrials.gov |
| October 2, 2026 | NCT07854496 | Effect of Otago vs. Sensorimotor Training on Balance and Fall Risk in People With Diabetes | Cairo University | Not applicable | Not yet recruiting | Type 2 Diabetes Mellitus (DM), Accidental Falls, Postural Balance | 40 | clinicaltrials.gov | |
| October 1, 2026 | NCT07852988 | Pancreatin Added to Standard Antihyperglycemic Therapy in Patients With Type 2 Diabetes | Silesian Centre for Heart Diseases | Phase 4 | Recruiting | Type 2 Diabetes (T2DM) | 100 | Poland | clinicaltrials.gov |
| October 1, 2026 | NCT07852715 | Educational Intervention for Self-Care in Patients With Coronary Heart Disease and Type 2 Diabetes | Suleyman Demirel University | Not applicable | Completed | Coronary Heart Disease (CHD), Diabetes Mellitus, Type 2 | 70 | Turkey (Türkiye) | clinicaltrials.gov |
| September 30, 2026 | NCT07849725 | Adaptation, Implementation, and Validation of an Innovative eHealth System for the Self-management, Monitoring, and Specialized Remote... | Universidad Antonio Nariño | Not applicable | Not yet recruiting | Diabetes (DM) | 200 | Colombia | clinicaltrials.gov |
| September 29, 2026 | NCT07847593 | Probiotics in Obese Patients Treated With Semaglutide | Nordic Biotic Sp. z o.o. | Not applicable | Completed | Obesity (Disorder), GLP-1 Receptor Agonist Treatment, Probiotic Intervention, Diabetes Mellitus Type 2 | 102 | Poland | clinicaltrials.gov |
| September 29, 2026 | NCT07847294 | The Effectiveness of an Occupation-Based Lifestyle Program in Individuals With Type 2 Diabetes | Ankara Medipol University | Not applicable | Recruiting | Diabete Type 2, Diabetes in Adults | 42 | Turkey (Türkiye) | clinicaltrials.gov |
| September 29, 2026 | NCT07847177 | Nurse-Led Self-Management and Breathing Intervention in Type 2 Diabetes | Aziza Ibrahim Mohamed | Not applicable | Completed | Type 2 Diabetes Mellitus, Cardiovascular Autonomic Dysfunction | 80 | Egypt | clinicaltrials.gov |
| September 29, 2026 | NCT07847112 | Soluble TREM-1 in Diabetes-Associated Cardiovascular Complications | Assiut University | Observational | Not yet recruiting | Type 2 Diabetes Mellitus, Cardiovascular Diseases, Coronary Artery Disease, Heart Failure, Arrhythmias, Arrhythmias... | 85 | clinicaltrials.gov | |
| September 29, 2026 | NCT07847099 | Platelet Indices and Blood Groups in Type 2 Diabetes Vascular Complications | Assiut University | Observational | Not yet recruiting | Type 2 Diabetes Mellitus, Vascular Complications | 100 | clinicaltrials.gov | |
| September 29, 2026 | NCT07846800 | The LifeMeds Cohort | Tilburg University | Observational | Not yet recruiting | Multimorbidity, Cancer, Cardio Vascular Disease, Chronic Respiratory Conditions, Type 2 Diabetes | 2,000 | clinicaltrials.gov | |
| September 29, 2026 | NCT07846319 | Evaluation of the Effectiveness of Implementing a Screening Strategy for the Diagnosis of Prediabetes and Type 2 Diabetes Mellitus in... | epHealth | Not applicable | Not yet recruiting | Diabetes Mellitus (Type 2), Prediabetes | 45,000 | Brazil | clinicaltrials.gov |
| September 28, 2026 | NCT07843862 | A Study of HRS-4729 Injection in Participants With Type 2 Diabetes | Fujian Shengdi Pharmaceutical Co., Ltd. | Phase 2 | Not yet recruiting | Type 2 Diabetes | 240 | China | clinicaltrials.gov |
| September 28, 2026 | NCT07843485 | A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes | Hoffmann-La Roche | Phase 3 | Recruiting | Obesity or Overweight, Type 2 Diabetes | 600 | United States | clinicaltrials.gov |
| September 25, 2026 | NCT07842757 | Preoperative Gastric Volume and High-Risk Gastric Content in Patients With Type 2 Diabetes Mellitus | Bakirkoy Dr. Sadi Konuk Research and Training Hospital | Observational | Not yet recruiting | Type 2 Diabetes Mellitus (DM), Gastric Ultrasound | 120 | Turkey (Türkiye) | clinicaltrials.gov |
| September 25, 2026 | NCT07841860 | A Study on the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-1596 Tablets in Healthy Participants With a Single Dose... | Fujian Shengdi Pharmaceutical Co., Ltd. | Phase 1 | Not yet recruiting | Weight Management, Type 2 Diabetes | 122 | China | clinicaltrials.gov |
| September 25, 2026 | NCT07841015 | A Study to Learn More About How Well Finerenone Works in Real-world in People With Type 2 Diabetes and Chronic Kidney Disease in Primary... | Bayer | Observational | Not yet recruiting | Type 2 Diabetes, Chronic Kidney Disease (CKD) Stages G2 to G3b | 800 | Mexico | clinicaltrials.gov |
| September 25, 2026 | NCT07840807 | Traditional Chinese Medicine Fasting Therapy, Ketone Levels, and Metabolic Improvements | The Seventh Affiliated Hospital of Sun Yat-sen University | Observational | Completed | Obesity & Overweight, Diabete Type 2, Metabolic Syndrome | 1,149 | China | clinicaltrials.gov |
| September 24, 2026 | NCT07839546 | Adherence to Clinical Guidelines for Management of Patients With Type 2 Diabetes Mellitus and Obesity | Aristotle University Of Thessaloniki | Observational | Completed | Guidelines, Diabetes Mellitus Type 2, Obesity Type 2 Diabetes Mellitus, Obesity (BMI > 35) and Diabetes Mellitus | 100 | Greece | clinicaltrials.gov |
| September 24, 2026 | NCT07839208 | Diastolic Dysfunction and Pulmonary Hypertension in T2DM With Microalbuminuria | Assiut University | Observational | Not yet recruiting | Diabetes Mellitus Type 2 | 120 | Egypt | clinicaltrials.gov |
| September 24, 2026 | NCT07837934 | Colchicine for Primary Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes | Tan Tock Seng Hospital | Phase 2 | Recruiting | Type 2 Diabetes Mellitus (T2DM), Atherosclerosis, Cardiovascular Diseases | 300 | Singapore | clinicaltrials.gov |
| September 24, 2026 | NCT07837856 | Therapeutic Adherence in Type 2 Diabetes | Instituto Mexicano del Seguro Social | Not applicable | Completed | Diabetes Mellitus, Type 2/Prevention & Control, Diabete Type 2, Treatment Adherence | 250 | Mexico | clinicaltrials.gov |
| September 23, 2026 | NCT07837258 | Serum Sulfate and Brain Function in Diabetic Encephalopathy | Dongzhimen Hospital, Beijing | Observational | Not yet recruiting | Diabetes Mellitus, Type 2, Cognitive Dysfunction, Cognitive Disorder, Brain Diseases, Metabolic | 220 | clinicaltrials.gov | |
| September 23, 2026 | NCT07836088 | A Clinical Study on Using Multimodal Ultrasound to Assess Muscle Mass in Metabolic Diseases | Zhangzhou Municipal Hospital | Observational | Recruiting | Metabolic Syndrome, Obesity, Sarcopenia, Type 2 Diabetes | 320 | China | clinicaltrials.gov |
Sponsors posting most
| Sponsor | New trials | Latest |
|---|---|---|
| Novo Nordisk A/S | 29 | October 26, 2026 |
| Eli Lilly and Company | 23 | October 28, 2026 |
| AstraZeneca | 22 | November 6, 2026 |
| Brigham and Women's Hospital | 13 | June 2, 2026 |
| Assiut University | 12 | November 6, 2026 |
| Humanis Saglık Anonim Sirketi | 10 | October 13, 2026 |
| Hoffmann-La Roche | 8 | October 22, 2026 |
| Riphah International University | 8 | August 13, 2026 |
| Steno Diabetes Center Copenhagen | 8 | June 12, 2026 |
| Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 8 | February 18, 2026 |
| Chong Kun Dang Pharmaceutical | 8 | January 26, 2026 |
| The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 7 | October 30, 2026 |
| Shanghai 6th People's Hospital | 7 | August 24, 2026 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 7 | June 26, 2026 |
| Jiangsu HengRui Medicine Co., Ltd. | 6 | November 6, 2026 |
| Kaiser Permanente | 6 | November 2, 2026 |
| University of Alabama at Birmingham | 6 | October 30, 2026 |
| Amgen | 6 | October 8, 2026 |
| Fujian Shengdi Pharmaceutical Co., Ltd. | 6 | September 28, 2026 |
| BrightGene Bio-Medical Technology Co., Ltd. | 6 | August 4, 2026 |
By phase
| Phase | New trials | Latest |
|---|---|---|
| Not applicable | 632 | November 9, 2026 |
| Observational | 278 | November 9, 2026 |
| Phase 1 | 100 | October 26, 2026 |
| Phase 3 | 87 | November 6, 2026 |
| Phase 4 | 73 | October 23, 2026 |
| Phase 2 | 71 | November 6, 2026 |
| Phase 1/2 | 12 | November 9, 2026 |
| Early phase 1 | 8 | September 15, 2026 |
| Phase 2/3 | 4 | June 30, 2026 |
By country
| Country | New trials | Latest |
|---|---|---|
| United States | 288 | November 9, 2026 |
| China | 194 | November 6, 2026 |
| Turkey (Türkiye) | 107 | November 9, 2026 |
| South Korea | 62 | October 28, 2026 |
| Canada | 60 | October 28, 2026 |
| Italy | 46 | November 2, 2026 |
| Spain | 45 | October 28, 2026 |
| Germany | 44 | November 9, 2026 |
| India | 39 | November 6, 2026 |
| Denmark | 35 | October 16, 2026 |
| Pakistan | 35 | October 8, 2026 |
| United Kingdom | 35 | September 1, 2026 |
| Mexico | 31 | October 28, 2026 |
| Taiwan | 31 | October 19, 2026 |
| Poland | 30 | November 5, 2026 |
| Brazil | 29 | October 28, 2026 |
| Japan | 27 | October 28, 2026 |
| Argentina | 25 | October 28, 2026 |
| Australia | 23 | October 28, 2026 |
| Malaysia | 22 | October 22, 2026 |
| France | 19 | October 28, 2026 |
| Indonesia | 19 | July 10, 2026 |
| Egypt | 18 | November 9, 2026 |
| Thailand | 17 | November 5, 2026 |
| Hungary | 17 | October 28, 2026 |
Where the register publishes
U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.